Science ❯Biotechnology ❯Vaccine Development

mRNA Technology

Cancer Vaccines Animal Studies Influenza Vaccines Trans-amplifying mRNA Viral Pathogens Clinical Trials

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

The move shrinks its staff to under 5,000 by year-end to cut $1.5 billion in annual expenses by 2027.

Stories older than 24h

UF Researchers Develop Universal mRNA Vaccine That Primes Immune System Against Tumors

Universal mRNA Vaccine Eradicates Tumors in Mice and Advances Toward Human Trials

BioNTech to Acquire CureVac for $1.25 Billion to Drive mRNA Cancer Therapy

Trans-amplifying mRNA vaccine delivers broad SARS-CoV-2 variant protection with 40-fold lower dosage

Georgia Detects First Bird Flu Case in Commercial Poultry Operation

Moderna's mRNA Vaccine Shows Superior Mpox Protection in Animal Studies